Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism

Applied Isotope Technologies ("AIT") announced that the company's Biochemimarker(TM) Discovery Products will be exclusively used for the analyses of samples from autistic children for metabolic biochemical assessment when they are placed in an Environmental Pediatric Room to be constructed at The Children's Institute in Pittsburgh, PA. Scott Faber, MD, a specialist in Autism Spectrum Disorders (ASD) will lead a team of scientists for this pilot project that aims to study the effects of environmental factors on this debilitating set of disorders. Duquesne University's Skip Kingston, Ph.D., will conduct the analytical tasks and provide the biochemimarker data. Funding for the initial phase...

Want to see the full article?

• Purchase this article for only $3.00